SG Alina^® is a variable-dose pen injector under development at Stevanato Group in collaboration with Cambridge Design Partnership. It is based on Axis-D intellectual property and technology exclusively licensed from pen injector device expert Haselmeier, for the treatment of diabetes.

The pen injector will be manufactured at Stevanato Group’s FDA audited facility in Germany. Access to tooling and sub-assembly equipment will be available to clients that are looking to balance investments for their device programs and also minimize time-to-market. Dedicated production tooling and lines are available if requested due to customization considerations or to support overall risk mitigation strategies. A range of final assembly equipment for this pen injector from our operations in Denmark and Italy can be made available to clients upon request or we can work with your existing equipment partner. Support from our glass primary container experts to final assembly and packing solutions are offered.

SG Alina^® features an appealing and functional design, including an easy-to-dial mechanism, optimized injection force for patient comfort, and a readable display. This platform pen injector offers a range of customization from dosing and color selection, to a more customized industrial design based on the needs of the pharmaceutical client.

The trademark Alina is a registered right exclusively owned by Stevanato Group or its affiliates.